Bernard Portevin

555 total citations
16 papers, 483 citations indexed

About

Bernard Portevin is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Bernard Portevin has authored 16 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Bernard Portevin's work include Peptidase Inhibition and Analysis (4 papers), Chemical Synthesis and Analysis (3 papers) and Click Chemistry and Applications (2 papers). Bernard Portevin is often cited by papers focused on Peptidase Inhibition and Analysis (4 papers), Chemical Synthesis and Analysis (3 papers) and Click Chemistry and Applications (2 papers). Bernard Portevin collaborates with scholars based in France and Canada. Bernard Portevin's co-authors include Guillaume De Nanteuil, G. REMOND, Philippe Pastoureau, Jacqueline Bonnet, J. Lépagnol, Michel Laubie, Bernard Serkiz, Michel Vincent, Yolande Hervé and Alain St. Pierre and has published in prestigious journals such as Journal of Medicinal Chemistry, Molecular Pharmacology and Tetrahedron Letters.

In The Last Decade

Bernard Portevin

16 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernard Portevin France 11 270 198 102 87 41 16 483
Ligaya M. Simpkins United States 13 229 0.8× 324 1.6× 75 0.7× 48 0.6× 57 1.4× 16 545
Martin S. Domalski United States 13 340 1.3× 189 1.0× 66 0.6× 57 0.7× 37 0.9× 22 571
Charles W. Lugar United States 11 221 0.8× 175 0.9× 55 0.5× 38 0.4× 69 1.7× 14 523
Tsuneo Yasuma Japan 12 153 0.6× 511 2.6× 72 0.7× 99 1.1× 30 0.7× 18 760
Seung Kyu Kang South Korea 17 567 2.1× 285 1.4× 101 1.0× 58 0.7× 58 1.4× 43 929
Xian‐Yun Jiao United States 14 301 1.1× 369 1.9× 48 0.5× 90 1.0× 24 0.6× 22 704
Richard T. Lewis United States 17 493 1.8× 302 1.5× 70 0.7× 97 1.1× 33 0.8× 31 754
Bernard Hulin United States 15 339 1.3× 307 1.6× 50 0.5× 39 0.4× 101 2.5× 23 645
David J. Madar United States 13 427 1.6× 255 1.3× 77 0.8× 33 0.4× 70 1.7× 20 639
Ana B. Bueno Spain 14 210 0.8× 323 1.6× 54 0.5× 151 1.7× 38 0.9× 24 599

Countries citing papers authored by Bernard Portevin

Since Specialization
Citations

This map shows the geographic impact of Bernard Portevin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Portevin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Portevin more than expected).

Fields of papers citing papers by Bernard Portevin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Portevin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Portevin. The network helps show where Bernard Portevin may publish in the future.

Co-authorship network of co-authors of Bernard Portevin

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Portevin. A scholar is included among the top collaborators of Bernard Portevin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Portevin. Bernard Portevin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Portevin, Bernard, et al.. (2008). Synthesis and CHK1 inhibitory potency of Hymenialdisine analogues. Bioorganic & Medicinal Chemistry Letters. 19(3). 841–844. 33 indexed citations
2.
Portevin, Bernard, Roy M. Golsteyn, Alain St. Pierre, & Guillaume De Nanteuil. (2003). An expeditious multigram preparation of the marine protein kinase inhibitor debromohymenialdisine. Tetrahedron Letters. 44(52). 9263–9265. 14 indexed citations
3.
Nanteuil, Guillaume De, et al.. (2001). Disease-modifying anti-osteoarthritic drugs: current therapies and new prospects around protease inhibition. Il Farmaco. 56(1-2). 107–112. 9 indexed citations
4.
Portevin, Bernard, et al.. (2000). 1,3-Diaryl-4,5,6,7-tetrahydro-2H-isoindole Derivatives:  A New Series of Potent and Selective COX-2 Inhibitors in Which a Sulfonyl Group Is Not a Structural Requisite. Journal of Medicinal Chemistry. 43(24). 4582–4593. 110 indexed citations
5.
Nanteuil, Guillaume De, Bernard Portevin, & J. Lépagnol. (1998). Prolyl endopeptidase inhibitors: A new class of memory enhancing drugs. Drugs of the Future. 23(2). 167–167. 27 indexed citations
6.
Portevin, Bernard, Michel Lonchampt, Emmanuel Canet, & Guillaume De Nanteuil. (1997). Dual Inhibition of Human Leukocyte Elastase and Lipid Peroxidation:  In Vitro and in Vivo Activities of Azabicyclo[2.2.2]octane and Perhydroindole Derivatives. Journal of Medicinal Chemistry. 40(12). 1906–1918. 9 indexed citations
7.
REMOND, G., Bernard Portevin, J Bonnet, et al.. (1997). Pharmacological profile of a novel series of NK1 antagonists. In vitro and in vivo potency of benzimidazolone derivatives. European Journal of Medicinal Chemistry. 32(11). 843–868. 17 indexed citations
8.
9.
Portevin, Bernard, G. REMOND, Yolande Hervé, et al.. (1996). New Prolyl Endopeptidase Inhibitors:  In Vitro and in Vivo Activities of Azabicyclo[2.2.2]octane, Azabicyclo[2.2.1]heptane, and Perhydroindole Derivatives. Journal of Medicinal Chemistry. 39(12). 2379–2391. 87 indexed citations
10.
Nanteuil, Guillaume De, et al.. (1995). New tripeptidic thrombin inhibitors. Influence of P2 and P3 residues on activity and selectivity. Bioorganic & Medicinal Chemistry. 3(8). 1019–1024. 13 indexed citations
11.
Morain, Philippe, et al.. (1994). Biguanide derivatives: agonist pharmacology at 5-hydroxytryptamine type 3 receptors in vitro.. Molecular Pharmacology. 46(4). 732–742. 22 indexed citations
12.
Kraus‐Berthier, Laurence, et al.. (1993). In vivo immunopharmacological properties of tuftsin and four analogs. Immunopharmacology. 25(3). 261–267. 3 indexed citations
13.
Marchand, Bernard, et al.. (1992). Synthesis and ACE inhibitory activity of the stereoisomers of perindopril (S 9490) and perindoprilate (S 9780).. PubMed. 9(1). 11–28. 25 indexed citations
14.
15.
16.
REMOND, G., et al.. (1982). Stereoselective synthesis of a new perhydroindole derivative of chiral iminodiacid, a potent inhibitor of angiotensin converting enzyme. Tetrahedron Letters. 23(16). 1677–1680. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ligaya M. Simpkins Breakdown of academic impact, for papers by Martin S. Domalski Breakdown of academic impact, for papers by Charles W. Lugar Breakdown of academic impact, for papers by Tsuneo Yasuma Breakdown of academic impact, for papers by Seung Kyu Kang Breakdown of academic impact, for papers by Xian‐Yun Jiao Breakdown of academic impact, for papers by Richard T. Lewis Breakdown of academic impact, for papers by Bernard Hulin Breakdown of academic impact, for papers by David J. Madar Breakdown of academic impact, for papers by Ana B. Bueno
Rankless by CCL
2026